Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

In partnership with the Silicon Valley Business Journal, we'll honor the Bay Area's top companies recognized as the Best ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

AmplifyBio said in a statement April 4, saying the decision to close followed months of efforts to keep the four-year-old ...

Doug Edgeton, CEO of North Carolina Biotechnology Center, shares insights on how the state has become a powerhouse in life ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...